Biotechnology company
Sibylla Biotech has raised €23M across 1 funding round from 9 investors, most recently a Series A round in Oct 2022. Based in Verona, Italy; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-10-04 | Series A | €23M |
| 3B Future Health Fund,CDP Venture Capital,Claris Ventures,Evolution Fund,Indaco Venture Partners,Seroba Life Sciences+3 more |
| View deal → |
